New AI eye scanner could save millions from blindness
NCT ID NCT06343350
First seen Mar 14, 2026 · Last updated Jun 18, 2026 · Updated 14 times
Summary
This study tested a new automated screening tool called OPTDR01 to detect diabetic retinopathy, an eye disease that can cause vision loss. The goal was to see if the tool works well in primary care settings, making it easier for people with diabetes to get screened. About 300 adults with diabetes who had no prior eye disease diagnosis took part. The tool automatically checks for signs of vision-threatening damage, aiming to catch problems early and prevent blindness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gastro SB
Chula Vista, California, 91910, United States
-
Gulf Coast Clinical Research
Houston, Texas, 77070, United States
-
Triwest Research Associates
San Diego, California, 92108, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.